Wells Fargo & Company Pmv Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.51 - $3.12 $3,924 - $8,108	2,599 Added 21.86%	14,491 $24,000
Q4 2023 Feb 09, 2024	BUY	$1.23 - $6.6 $2,902 - $15,576	2,360 Added 24.76%	11,892 $36,000
Q3 2023 Nov 13, 2023	SELL	$6.01 - $8.93 $30,753 - $45,694	-5,117 Reduced 34.93%	9,532 $58,000
Q2 2023 Aug 15, 2023	BUY	$3.94 - $6.27 $32,036 - $50,981	8,131 Added 124.75%	14,649 $91,000
Q1 2023 May 12, 2023	BUY	$4.77 - $9.16 $31,090 - $59,704	6,518 New	6,518 $31,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $10,875 - $16,389	-954 Reduced 33.57%	1,888 $23,000
Q2 2022 Aug 12, 2022	BUY	$9.23 - $22.43 $4,974 - $12,089	539 Added 23.4%	2,842 $41,000
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $129,638 - $205,450	-8,724 Reduced 79.11%	2,303 $48,000
Q4 2021 Feb 14, 2022	BUY	$19.99 - $30.24 $219,690 - $332,337	10,990 Added 29702.7%	11,027 $254,000
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $751 - $1,024	28 Added 311.11%	37 $1,000
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $86,774 - $111,558	-3,098 Reduced 99.71%	9 $0
Q1 2021 May 13, 2021	SELL	$30.66 - $49.5 $121,904 - $196,812	-3,976 Reduced 56.13%	3,107 $103,000
Q4 2020 Feb 09, 2021	BUY	$31.86 - $61.51 $225,664 - $435,675	7,083 New	7,083 $436,000

101

43.4M

500

100

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $69.8M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.